UBS Maintains Buy on MetLife, Lowers Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Brian Meredith has maintained a Buy rating on MetLife (NYSE:MET) but has lowered the price target from $87 to $82.

February 05, 2024 | 7:35 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS maintains a Buy rating on MetLife but lowers the price target from $87 to $82.
While the maintenance of a Buy rating by UBS suggests continued confidence in MetLife's fundamentals, the reduction in the price target could signal a tempered outlook on the stock's short-term price performance. This mixed signal might lead to neutral short-term price movement as investors digest both the continued endorsement and the lowered expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90